The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.

    Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.

    Britta Shoot

    Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease. Read more…

Recent articles

  • Research updates, October 27
    Science
    Miles W. Griffis

    Research updates, October 27

  • National COVID-19 trends, October 27
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, October 27

  • The real story behind the “October slide”
    Health, Science
    Lorraine Boissoneault

    The real story behind the “October slide”

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

The real story behind the “October slide”The real story behind the “October slide”Lorraine Boissoneault
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Britta Shoot
Research updates, October 20Research updates, October 20Miles W. Griffis
National COVID-19 trends, October 27National COVID-19 trends, October 27Betsy Ladyzhets
Conferences and advocacy events for IACCs must require maskingConferences and advocacy events for IACCs must require maskingWhitney Fox

Policy & Advocacy

Science

  • nurse wiping the arm of a patient
    April 16, 2024

    Research updates, April 16

  • April 9, 2024

    Hidden disability: The quiet struggle with Long Covid in Kenya

  • red and blue industrial exhaust fans
    April 9, 2024

    Research updates, April 9

  • April 2, 2024

    How patient-led research could speed up medical innovation

  • set of medical equipment for taking analysis from vein
    April 2, 2024

    Research updates, April 2

  • March 26, 2024

    Want to enroll in a Long Covid clinical trial? This new project helps track them.

Previous Page
1 … 33 34 35 36 37 … 40
Next Page

Covid-19

Health

Commentary

  • December 19, 2023

    Covid-19 in the hierarchy of the Gaza health crises

  • December 12, 2023

    Virtual town hall recording now available

  • November 28, 2023

    Support Long Covid journalism for #GivingTuesday

  • November 28, 2023

    Share your story ideas at The Sick Times’s Virtual Town Hall

Previous Page
1 … 25 26 27 28
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...